Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

BACKGROUND: β-thalassemia is a hereditary blood disorder resulting in ineffective erythropoiesis and anemia. Management of anemia with regular blood transfusions is associated with complications including iron overload. Here, we report long-term safety and efficacy results of the first clinical stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Piga, Antonio, Longo, Filomena, Gamberini, Maria Rita, Voskaridou, Ersi, Ricchi, Paolo, Caruso, Vincenzo, Pietrangelo, Antonello, Zhang, Xiaosha, Shetty, Jeevan K., Attie, Kenneth M., Tartaglione, Immacolata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726852/
https://www.ncbi.nlm.nih.gov/pubmed/36505885
http://dx.doi.org/10.1177/20406207221134404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726852/
https://www.ncbi.nlm.nih.gov/pubmed/36505885
http://dx.doi.org/10.1177/20406207221134404

Ejemplares similares